Final Announcement for Global Pharmacovigilance 2019

13th Global Pharmacovigilance and clinical trials summit
March 28-29, 2019
Osaka, Japan

Dear 

It is an honor for us to invite you as a speaker/Delegate at Global Pharmacovigilance 2019 which is scheduled to be held in the month of March 28-29, in the magnificent city of Osaka, Japan. The conference will feature interactive get together of researchers, scientists, students and entrepreneurs illuminating the facts and recent researches in the sward of Pharmacovigilance.

Our confirmed Speakers:

Dr. Jacob Joseph, Harward Medical School, USA

Dr.Ujwala Salvi, Nucleon Therapeutics, India

Mr. Chi Chen, E&Y, China 

Dr. Meenal Patwardhan, AbbVie, USA

Mr. Rajiv Joshi, E&Y, India

Dr. Essam, Celyad llc, Belgium

Dr. Carole, Sun Pharma, Japan

Mr. Robert, Accenture, Spain

Mr. Ravish Kumar, Salzman Group, Australia

Dr. Abdeen, Ministry of health, UK.

Dr. Ripal Gharia, Cliantha research, India

Mr. Mohammed Gayoor khan, NFPS, Malaysia

Dr. lorelei, Vice President, Pepgen Corporation, USA

Dr. Muhammed Waser Anwar, Evolet Healthcare Pvt Limited,India.

Dr. Jean Wright, Abbvie, USA.

The honor of your noble presence will adorn the conference.

We look forward to your presence. Kindly do reply to us about your interest.

Have a Good Day.
Regards,
Zoey Williams | Program Manager

                                      Plan your trip to Osaka, Japan

Theme: Promulgating the prevention of adverse drug reaction

The conference offers richer experiences for Exhibitors, Sponsors, Plenary Sessions, keynote talks, Poster presentations, B2B meetings, and networking panels.
For Conference details, please visit: https://bit.ly/2HwRNwR

Benefits

·         Best platform to develop new partnership & collaborations.

·         Network development with both Academia and Business.

·         Recognition to your products and services in the world market through our website.

·         Shape and raise your corporate image through logo branding.

·         Special privileges on group registrations.

·         Develop new client relationships and strengthen the existing ones (B2B Meeting).

Participating Companies:

·         Abbvie,USA

·         E&Y, China

·         Salmanz Group, Australia

·         Nucleon Therapetics, India

·         Saudi Patient safety Center, Saudi

·         AlphaBeta Pharma, UK

·         King Abdullah Medical City (KAMC)

·         Takeda, USA

Please let me know your confirmation at the earliest convenience.

Best Regards   Zoey A Williams| Program Coordinator   Global Pharmacovigilance 2019   Ph: 4896666555 Ext:6028   Email:  globalpharmocovigilance2019@gmail.com

Mid Term Announcement of the conference- GPV 2019

Greetings of the day!!

We heartily welcome all the participants throughout the globe to participate in the conference titled 13th Global Pharmacovigilance and clinical trials summit. This event would be a great opportunity to gather knowledge as well as experience in the field of pharmacovigilance and clinical trials.

Session of the conference:

Pre-Clinical and Clinical Trials

Adverse Drug Reactions

Good Pharmacovigilance Practice

Drug Safety

Clinical Trial Protocols

Diversity in Industrial Clinical Trials and Clinical Research

Clinical Research and Statistics

Clinical Database Management

Medical and Clinical Case Reports

Hospital and Industrial Pharmacy

Clinical Data Management and Analytics

Clinical Trial Site Selection and Management

Medical and Clinical Case Reports

Biopharmaceutical Sciences

Our Confirmed Speakers:

Keynote:(Day 1)

Dr.Jacob Joseph, Harward Medical School, USA

Dr.Ujwala Salvi, Nucleon Therapeutics, India

Dr.Omer, Sanofi, Canada

Dr.Ashok, Clinfomatrix, USA

Other Speakers

Mr.Chi Chen, E&Y, China 

Dr.Meenal Patwardhan, Abbvie, USA

Mr.Rajiv Joshi, E&Y, India

Keynote (Day 2)

Dr.Essam, Celyad, Belgium

Dr.Carole, Sun Pharma, Japan

Mr.Robert, Accenture, Spain

Session Speakers:

Mr.Ravish Kumar, Salzman Group, Australia

Dr.Abdeen, Ministry of health, UK.

Dr.Ripal Gharia, Cliantha research, India

Mr.Mohammed Gayoor khan,NFPS,Malaysia

Participating Companies:

·         Abbvie,USA

·         E&Y, China

·         Salmanz Group, Australia

·         Nucleon Therapetics, India

·         Saudi Patient safety Center, Saudi

·         AlphaBeta Pharma, UK

·         King Abdullah Medical City (KAMC)

·         Takeda, USA

Conference Announcement-Global Pharmacovigilance 2019

Greetings of the day,

This year is shaping up to be another exciting one for the Pharmacovigilance conference team. With nearly 30 Speakers already booked for the year, our thought leaders are looking forward to learning, networking, and presenting their work at a host of the event.

Here is a sampling of our first quarter of the conference. We hope to see you in person very soon!!!!

For more details visit: https://bit.ly/2HwRNwR

Collaboration:

NFPS-National Forum of Pharmacy students

Media Partners:

BioBased Press

Tabeeby

Japan Attractions

Conference Locate

Placidway

Keynote Speakers:

Dr.Jacob Joseph, USA

Dr.Ashok Srivastava, USA

Conference Announcement-Global Pharmacovigilance 2019

We are happy to announce Almac's Group as Exhibitor at the upcoming “12th Global Pharmacovigilance & Clinical Trials Summit” ( Global Pharmacovigilance 2018) on July 16-17, 2018

Hurry up!! Slots are Limited!! Join us as a Speaker/ Delegate.

To register : https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

For Queries E: globalpharmacovigilance123@gmail.com

Join us! 12th Global Pharmacovigilance & Clinical Trials Summit | Few days ahead!! As we are few days away from 12th Global Pharmacovigilance & Clinical Trials Summit happening on July 16-17, 2018 in Sydney, Australia.

Venue: Mercure Sydney, 818-820 George St, Sydney NSW 2007, Australia


GlobalPharmacovigilance2018 would lay a platform for the interaction between experts around the world and aims in accelerating scientific discovery.

http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

Expertise in Drug Discovery, Chemistry, Pre-Clinical Development, Clinicalresearch and Drugdevelopment, #Pharmacology and Pharmaceutics, Pharmacovigilance, Risk Management and Drugsafety, Clinicaloutcomes, Adverseevent Reporting System, Pharmacovigilance and its scope, Regulatory Safety Updates, Difficulties in Pre and Post marketing Surveillance, Biosimilars and Biologistics. and many more can share your research and listen to the expertise in the same field.


Email: globalpharmacovigilance123@gmail.com

globalpharmacovigilance@conferenceseries.net

#GroupDiscount!

https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

Email globalpharmacovigilance123@gmail.com for details!

Participants interested to #register in group of 3 and more for #Globalpharmacovigilance2018 can contact us to avail #discounted prices.

Researchers in #pharmacovigilance, #clinical trials, #biosimilars, #regulatoryaffairs, #drug safety, #epidemiology, #Pharmacology, #toxicology #clinicalresearch can actively take part in 12th Global Pharmacovigilance & Clinical Trials Summit | July 16-17, 2018 Sydney, Australia

Come Let’s Bring a Transformation in the Scientific Society :

---------------------------------------------------------------------------

The Young Researchers Forum offers young researchers the possibility to meet and discuss research topics and methodologies, share and develop ideas, learn from each other and gain knowledge from senior researchers.

Meet leading experts in the field of Pharma, Pharmacy, pharmaceutical industry. Students can present their research

https://globalpharmacovigilance.pharmaceuticalconferences.com/young-researchers-forum.php

Young Researcher Sessions are organized at the Global Pharmacovigilance 2018, to provide a unique platform for Young Researchers/Investigators for presenting latest research projects with an in-depth analysis. Conference Series LLC Ltd cordially invites Young Researchers from Universities/Institutes/Industries to present a short oral presentation during the forum. These oral presentations should be of 10-20 minutes duration in related scientific track followed by 5 minutes question hour. Therefore, presenters are encouraged to give comprehensive and dynamic talks.

For more details mail us at globalpharmacovigilance123@gmail.com

Join us in #Australia to meet the #eminent persons in the field of #Pharma, #Biotech and #HealthCare interested in #Pharmacovigilance, #Clinicaltrials and #Drugsafety.

12^th Global Pharmacovigilance & Clinical Trials Summit
July 16-17, 2018 
Sydney, Australia

Register Now!!

http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

For Queries mail us at globalpharmacovigilance123@gmail.com

Few #Speaker slots left!!

Pharmacovigilance & #Clinical Trials #Summit 

July 16-17, 2018 #Sydney, #Australia 

Hurry to #submit your #abstract and #enroll your #participation in #Global Pharmacovigilance 2018 #Conference. 

Submit your abstract @ https://lnkd.in/fjt8WES #

For queries, mail us at globalpharmacovigilance123@gmail.com

Meet Inspiring Speakers and Experts at 12th Global Pharmacovigilance & Clinical Trials Summit on July 16-17, 2018 Sydney, Australia

To book your slot... and confirm your registration, visit our online link
https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

For queries, mail us at globalpharmacovigilance123@gmail.com

Adverse Drug Reaction (ADR) is that the contrary reaction caused by taking a medicine. several Adverse Drug Reactions represent an awesome facet effects of the drug's therapeutic effects and ar thanks to administration of single dose or prolonged usage of drug. These reactions ar caused by one drug or combination of multiple medication. ADRs is native i.e, restricted to bound location or it is general i.e, unfold throughout whole circulation. Acoording to US FDA an adverse drug reaction is severe once it ends up in death of patient or causes permanent harm or important incapacity in patient’s body functions. Adverse Drug Reactions of medicine is studied by reportage the mechanism of adverse drug reactions and maintaining the drug safety systems. This track is concerning expected and un-expected drug reactions and its reportage makers, Professionals, and shoppers will report Post promoting reports on adverse effects.

For more updates regarding the conference, mail us at globalpharmacovigilance123@gmail.com

                                

Good Pharmacovigilance Practices (GVP) begins with the acquisition of complete information from spontaneous adverse event reports. GVP characterizes the adverse event details, baseline patient characteristics, medical aid details, identification of the events and clinical course of the event. The role of excellent Pharmacovigilance observe and Pharmacoepidemology in Risk Management is principally to increase the chance of useful effects of a drug in a very population than the chance of adverse effects and to keep up the nice reportage Practices by avoiding the most important issues in risk management. conjointly it's vital to consider Signal investigation by gathering the knowledge on new or unknown drug effects that's doubtless caused by a medication which finally ought to result in making certain safety. The pharmacovigilance and clinical trials services providing corporations ought to have the Pharmacovigilance certification.

Share your research @ Global Pharmacovigilance 2018 Conference.
https://globalpharmacovigilance.pharmaceuticalconferences.com/

The global pharmacovigilance (PV) market size was estimated at USD 3.40 billion in 2016 and is anticipated to witness a CAGR of 13.1% over the forecast period. Increasing incidence of Adverse Drug Reactions (ADRs) is expected to accelerate the demand for pharmacovigilance services

The main aim of pharmacovigilance is to supply complete and clear info associated with drug safety and varied risks and advantages related to them. Pharmacovigilance will facilitate in providing info of unintended and severe adverse events that couldn't be provided by clinical trials involving in-vivo technique. It enhances the impact of pharmacovigilance on patient welfare and public health and to grasp what's pharmacovigilance. This track offers a short discussion on Pharmacovigilance role in health care system. Pharmacovigilance legislation offers associate degree outlook on the principles and laws to follow in Pharmacovigilance observe. The Role of pharmaceutical company industries within the improvement of pharmacovigilance system is extremely crucial to take care of the protection knowledge, Detection and analysis of drug safety signals through manual and medical devices reportage. Pharmacovigilance scope additionally deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in flavourer medicines.

For more updates regarding the conference, mail us at globalpharmacovigilance123@gmail.com

P.S: https://globalpharmacovigilanceconferences.blogspot.in/

Global Pharmacovigilance 2018 is comprised of #keynote and #speakers sessions on latest cutting edge research designed to offer comprehensive global #discussions that address current #issues in Global #Pharmacovigilance 2018

Submit your abstract to any of the mentioned tracks

Track 1: Pharmacovigilance Significance & Scope
Track 2: Good Pharmacovigilance Practice
Track 3: Adverse Drug Reaction
Track 4: Drug Safety
Track 5: Pharmacokinetics and Pharmacodynamics
Track 6: Innovations in Pre-clinical Research
Track 7: Clinical Research
Track 8: Clinical Trials
Track 9: Innovations in Clinical Trials
Track 10: ClinicalTrials on Various #Disorders
Track 11: Clinical Data Management and #Statistics
Track 12: Clinical and Medical Case Reports
Track 13: Pharmacovigilance and #Risk Management
Track 14: RegulatoryAffairs
Track 15: Challenges in Pharmacy Practice
Track 16: Pharmaceutical Toxicology

With the grand success of Pharmacovigilance Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce 12th Global Pharmacovigilance & Drug Safety Summit during July 16-17, 2018 Sydney, Australia with the theme “Comprehend Multiple Facets of Pharmacovigilance, Drug Safety and Clinical Trials”. This is a 2 day Mega Event offering Exhibition, at venue to showcase the new and emerging technologies with Keynote presentation, Oral, YRF (Student Presentation), poster, e-poster Presentations.

GLOBAL PHARMACOVIGILANCE 2018

With the grand success of Pharmacovigilance Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce 12th Global Pharmacovigilance & Drug Safety Summit during July 16-17, 2018 Sydney, Australia with the theme “Comprehend Multiple Facets of Pharmacovigilance, Drug Safety and Clinical Trials”. This is a 2 day Mega Event offering Exhibition, at venue to showcase the new and emerging technologies with Keynote presentation, Oral, YRF (Student Presentation), poster, e-poster Presentations.

Conference Highlights

• Pharmacovigilance Significance & Scope
• Good Pharmacovigilance Practice
• Adverse Drug Reaction
• Drug Safety
• Pharmacokinetics and Pharmacodynamics
• Innovations in Pre-clinical Research
• Clinical Research
• Clinical Trials
• Innovations in Clinical Trials
• Clinical Trails on Various Disorders
• Clinical Data Management and Statistics
• Clinical and Medical Case Reports
• Pharmacovigilance and Risk Management
• Regulatory Affairs
• Challenges in Pharmacy Practice
• Pharmaceutical Toxicology

Special Issues

•  All accepted abstracts will be published in respective Supporting International Journals.
•  Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: https://globalpharmacovigilance.pharmaceuticalconferences.com/